Visit us at these upcoming events:
o #RSCPoster Twitter Conference: March 2-3
o Biotrans 2021: July 19-22
BioNukleo is setting up a collaboration with the German company abcr GmbH. With the current agreement, abcr GmbH will expand their existing portfolio of biocatalysts and take over the sales process of our catalog products. BioNukleo and our customers will benefit from abcr GmbH’s established global sales structure and more than 30 years of experience on specialty chemicals and catalog business.
BioNukleo will join the 10th International Congress on Biocatalysis on August 30 - September 3, 2020, in Hamburg, Germany. Hopefully we will also be able to present our work in a short talk.
BioNukleo will be present at the 6th International Conference on Biocatalysis in Non-Conventional Media on May 7 - 9, 2020, in Milan, Italy. Be sure to check out our poster!
The 6th BioProScale Symposium “Innovative scale-up and scale-down for bioprocess intensification” will take place from March 30 - April 1, 2020, in Berlin, Germany. The event is hosted by our close collaborators the Chair of Bioprocess Engineering at the TU Berlin. You can also meet us there!
DUE TO COVID-19 WORRIES NOW POSTPONED UNTIL MARCH 2021
BioNukleo will join the 5th multistep enzyme catalyzed processes conference on March 30 - April 2, 2020, in Aachen, Germany. The conference promises to bring together biologists, chemists and engineers from academia and industry to share their knowledge and break new ground in the multi-step enzyme catalysis.
DUE TO COVID-19 WORRIES NOW POSTPONED UNTIL SEPT 2021
BioNukleo will present a pitch at the 4th European Chemistry Partnering on February 27, 2020, in Frankfurt, Germany. Join the audience at 3:48 pm in room Solar or meet up with us on site!
BioNukleo will join the Protein Engineering Congress on November 12 - 13, 2019, in Frankfurt, Germany.
BioNukleo will visit the world's largest pharmaceutical exhibition CPhI Worldwide on November 5 - 7, 2019, in Frankfurt, Germany. We are looking forward to meeting you there!
BioNukleo will be featured in the 21st Guide to German Biotech Companies 2020 issued by Biocom. For now 21 years this guide has served as international calling card of the young German biotech industry - and this year we are a part of it. The finished book will be expected in November this year. Stay tuned!
BioNukleo will join the Green China 2019 1st International Green and Sustainable Chemistry Conference on October 17 - 19, 2019, in Beijing, China. We are looking forward to meeting you there!
BioNukleo will visit the 14th International Symposium on Biocatalysis and Biotransformations (BioTrans 2019) on July 7 - 11, 2019, in Groningen, The Netherlands.
BioNukleo will visit the Chemspec europe - the 34th International Exhibition for Fine and Speciality Chemicals on June 26 - 27, 2019, in Basel, Switzerland. We are looking forward to meeting you there!
BioNukleo will present at the BIONNALE on May 7, 2019, in Berlin, Germany. See us at the cooperation track!
BioNukleo joined the "Pack a big Wallop" symposium on latest developments in the field of small molecules. The event was hosted by the MDC on April 10, 2019 in Berlin, Germany.
BioNukleo joined the 4 day EMBO workshop on enzymes, biocatalysis and chemical biology on September 9 - 12, 2018, in Pavia, Italy.
BioNukleo was at the 14th Nucleic Acids Forum on July 6, 2018, in London, United Kingdom. The forum was a great opportunity to meet new collaboration partners. Thanks to the Royal Society of Chemistry for the excellent organisation of this interesting day.
BioNukleo was at the Cross-Innovation-Workshop: "Laborautomation und Bioanalytik" on June 28, 2018, in Berlin, Germany.
BioNukleo presented at the BIONNALE on June 20, 2018, in Berlin, Germany - the largest networking event for life sciences in the German capital region. It was a great opportunity to meet new and old collaboration partners and get updated on current local research. Thank you Berlin Partner for the excellent program and the organization of 1 on 1 meetings!
BioNukleo joined the 8th "Innovationskongress Chemie und Biotechnologie" on May 30, 2018, in Magdeburg, Germany. Members of industry and academic research presented and discussed about material cylces, optimized synthesis and innovations in modern chemistry and biotechnology.
BioNukleo was at the German Biotech Days that took place on April 18 and 19, 2018, in Berlin, Germany. Among the highlights were the lively discussion between biotech company representative Dr. Mariola Söhngen (Mologen AG) and several members of the German Bundestag, as well as minister Peter Altmaier emphasizing the importance of biotechnology for the German economy.
BioNukleo joined the German Research Summit on April 17, 2018, in Berlin, Germany. The aim of the Research Summit 2018 was to come together and formulate answers to some of the most pressing questions in German research- and innovation policy.
BioNukleo's CEO Katharina Paulick contributed to the podium discussion Businesswomen! ("Unternehmerinnen!") on January 18, 2018, in Berlin, Germany. Organized by the Alphazirkel GmbH, female entrepreneurs discussed about how females think and act in business.
BioNukleo presented its enzymatic technology for the production of modified nucleosides and nucleotides at the 17th annual PepTalk Protein Science Week on January 8 - 12, 2018, in San Diego, USA.
The objective of the one-day symposium was to show recent developments for the applications of nucleosides, nucleotides and nucleic acids in medicinal chemistry. Applications are still found in the fields of antivirals, anticancer compounds or antisense oligonucleotides. But also new therapeutic applications are found like in immune-oncology, which opens many new possibilities. Prof. Jens Kurreck, Coach of the BioNukleo Team, presented BioNukleo's sustainable technology which can be used for the production of nucleosides and nucleotides.
Katharina Paulick, one of BioNukleo's CEOs, gave a talk at the `Career Day' of the Max Delbrück Centre for molecular medicine in Berlin. Encouraging PhD students to get entrepreneurs, she talked about first steps founding a startup and about financing possibilities. Also her own career as a scientist and entrepreneur was in focus. Subsequent, she made contact to the 3Is Pharma Innovation Initiative and will show them how BioNukleo was founded, funded and growing. As BioNukleo got and gets much advice from coaches and other companies, it is important to keep young students informed about the startup scene in Germany.
We proudly announce the start of „Network for Pharma Solutions – NetPhaSol“. This cooperation network for drug development serves as a platform for research, development and marketing of new products, processes and services. The primary focus are the first value chain stages of a drug development cycle - however, further development stages are not excluded. BioNukleo is now broadening NetPhaSol´s profile with its expertise in Drug development. The initiative will present its portfolio at the drug development meeting „Treffpunkt Wirkstoffentwicklung“ on 16th October in Berlin
Source: Berlin Partner for Business and Technology GmbH
Most of the symposium was dedicated to plenary lectures from invited speakers as well as short talks. There also were poster sessions where selected participants could present their research. The schedule also included social activities, such as a welcome reception/dinner, lunch and coffee breaks as well as a guided city tour.
Inspiring talks and a great platform to meet and find collaboration partners.
CEO Katharina presented BioNukleo in the Start-up session.
From the german "Stifterverband", BioNukleo gets the label "Innovative through research" due to it's high expenses in biocatalytic research.
Together with Labvolution, the Biotechnika was in May 16-18 in Hannover, Germany. The specialist trade fair for innovative lab equipment and laboratory workflow optimization "LABVOLUTION with Life Science Event BIOTECHNICA" has a new thematic focus. BioNukleo made contact to customers, distributers and had a close look at the new smart lab- showing the future of molecular biology. In fact, BioNukleo has also access to the lab of the future from the TU Berlin, with different robots facilitation scientist´s work.